UK SME offers a rapid molecular diagnostic technology for infectious disease detection and seeks commercial, outsourcing, and investment partners
A UK SME, spun out from a leading university, is developing a diagnostic platform for the rapid and multiplexed detection of infectious diseases through the fast amplification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company also provides an assay development service enhanced by artificial intelligence (AI) and machine learning. It seeks commercial, outsourcing, and investment agreements.